In addition, we provide various streptavidin and anti-species plates and buffer products as catalogue items. Also check out our Upcon® nanoparticle-based detection technology that is well suited for lateral flow applications.Kaivogen’s main customer group consists of IVD companies, for whom Kaivogen acts as an OEM manufacturer of components for IVD assays and kits. Other customer groups include research foundations and academic research groups.

Kaivogen’s main customer group consists of IVD companies, for whom Kaivogen acts as an OEM manufacturer of components for IVD assays and kits. Other customer groups include research foundations and academic research groups.

Kaivogen in numbers

In 2017 Kaivogen celebrated its 10th anniversary. By the end of 2018, we had coated well over 700 000 microplates enabling the analysis of over 40 000 000 patient samples using our plates. In 2016 we got our new plate coating line operational, providing a batch size of over 2000 plates. We have highly skilled personnel with combined experience of over 340 years in the field, including 6 PhDs specialized in bioanalytical applications – all ready to help you achieve your goal.

Our growth

From a small and ambitious three-person start-up, Kaivogen has grown over the years into a solid and versatile full-service biotech company. Kaivogen currently employs more than twenty highly motivated people who together help to create a lively and inspiring atmosphere that supports the ongoing activities and cultures the growth of new ideas and collaborations.

During the years, Kaivogen has had the privilege to participate in numerous assay development projects and other ventures. The first big endeavour was the establishment of the streptavidin coating line that brought the company into existence and saved a global IVD company from a lot of trouble when their earlier microplate provider discontinued streptavidin plate coating. After that, Kaivogen has helped several companies, for example, by solving problematic results through technology transfer, by renewing old assay concepts and by taking part in co-funded assay development projects. More recently, through the launch of Upcon®, Kaivogen has pioneered the introduction of a new detection technology based on upconverting nanoparticles.

Our core values continue to build around flexible and customer-oriented operation, consistent high quality and proven reliability.

Kaivogen - Model SA96 -Streptavidin Plates

Technical Data